Reshma Jagsi | |
---|---|
Born | England | April 28, 1974
Spouse | John A. E. Pottow |
Academic background | |
Education | BA, Government, 1995, Harvard College MD, Harvard Medical School DPhil, Comparative Social Policy, University of Oxford |
Thesis | A comparative analysis of the political and professional regulation of junior doctors' work hours in the United States and United Kingdom. (2001) |
Academic work | |
Institutions | Emory University |
Reshma Jagsi (born April 28,1974) is an American Radiation oncologist. She is the Lawrence W. Davis Professor and Chair in the Department of Radiation Oncology [1] and Senior Faculty Fellow in the Center for Ethics at Emory University. Overall,she is the author of over 450 published articles in peer-reviewed medical journals and continues scholarly research in three primary areas of interest:breast cancer,bioethics,and gender equity,with the support of grants from the National Institutes of Health (NIH),the Doris Duke Charitable Foundation,and the Susan G. Komen Foundation,for which she serves as a Senior Scholar.
Jagsi was born on April 28,1974 [2] in England. Her family moved to the United States in 1978 so her father could redo his residency,which took three years,before settling in Texas. [3] As a student at Midway High School,Jagsi recorded a perfect score on her Scholastic Aptitude Test as a 16-year-old senior. [4]
After graduating from high school,Jagsi enrolled at Harvard College in Boston and majored in Government. [3] In 1994,Glamour magazine listed Jagsi amongst their Top 10 College Women,earning a $1,000 scholarship for winning the competition. [5] She also received both the Fay Prize,the Radcliffe College's highest undergraduate honor,awarded to the female graduate showing greatest promise in scholarship,conduct,and character, [6] and Harvard College's Freund Prize,which is awarded to the summa cum laude graduate ranked first in the class,after completing her Bachelor of Arts's degree with Straight-As. [7] Following this,she enrolled at Harvard Medical School with an entering class of more women than men. [8] As a graduate student,she was named a Marshall Scholar and received a full tuition scholarship for two or three years of study at any British university,as well as books,travel and living expenses. [9] While concurrently enrolled for her medical degree at Harvard,Jagsi enrolled at the University of Oxford to earn an MSc degree in Comparative Social Research and DPhil in Social Studies. [10] She went on to complete her residency training in radiation oncology at Massachusetts General Hospital's Harvard Radiation Oncology Program and completed fellowship training in ethics at Harvard's Center for Ethics. [11]
Jagsi joined the faculty at Michigan Medicine in 2006 and worked within the Center for Bioethics and Social Sciences in Medicine studying issues of bioethics arising from cancer care. [12] Building on her seminal study published in the New England Journal of Medicine in 2007,documenting the "gender gap" in the authorship of articles published in major medical journals, [13] she went on to receive grants from the American Medical Association,Burroughs Wellcome Fund,Robert Wood Johnson Foundation,and the National Institutes of Health to develop influential studies of challenges and interventions to promote women's advancement in the field of medicine. [14] In 2012,she was the lead author of the paper,Gender Differences in the Salaries of Physician Researchers,published in JAMA,which found that women earned an average of $12,194 less than men a year when all other factors remained the same. [15] A few years later,she led another study which found that 30 per cent of female doctors in the United States have been sexually harassed or assaulted in the workplace,compared to only 4 per cent of American male doctors. [16] Beyond focusing on gender,Jagsi also conducted numerous large observational studies and leads national clinical trials seeking to optimize the quality of breast cancer care. [7] In recognition of these contributions,she was appointed to the Early Breast Cancer Trialists Collaborative Group Steering Committee [14] and the San Antonio Breast Cancer Symposium program planning committee. [17] At the 2020 Symposium,she presented on the disconnect between physicians and patients' radiation therapy side effects. [18]
As a professor and deputy chair of the Department of Radiation Oncology at the University of Michigan,Jagsi was appointed director of the Center for Bioethics and Social Sciences in Medicine at Michigan Medicine in 2017. [12] In this role,she continued to study sexual harassment and gender inequality in academic medicine [19] and earned the American Medical Women's Association Gender Equity Award for "promoting equality in the education and training of physicians by assuring equal opportunities for women and men to study and practice medicine." [20] Jagsi was also elected to the American Society for Clinical Investigation [21] and to the Board of Directors for the American Society of Clinical Oncology. [22] Jagsi's work on research on inflammatory breast cancer and innovative radiotherapy approaches to intensify treatment was also supported by the Susan G. Komen Foundation. [7]
In March 2019,Jagsi was named the Newman Family Professor at the University of Michigan Medical School. [23] While serving in this role,she was the recipient of the Association of American Medical Colleges Group on Women in Medicine and Science Leadership Award for her "significant impact on the advancement of women’s roles in academic medicine and science." [24] She was also elected a Fellow of the American Society of Clinical Oncology,the American Society for Radiation Oncology,and the American Association for Women Radiologists. [7] Her work directly inspired a multi-million dollar investment by the Doris Duke Foundation to launch a national extension of a unique program she first evaluated titled the "Doris Duke Foundation's Fund to Retain Clinical Scientists." [25]
During the COVID-19 pandemic in North America,Jagsi was elected a Hastings Center Fellow for her "outstanding accomplishments whose work has informed scholarship and public understanding of complex ethical issues in health,health care,science,and technology." [26] Throughout the pandemic,she studied how income inequality for women in oncology was exacerbated by COVID-19. She found that "because the onus of balancing work and family continues to be primarily on women,the pandemic has had a more severe effect on the careers of female oncologists." [27] By December,she was the recipient of the Center for the Education of Women's Carol Hollenshead Inspire award and the LEAD Woman Oncologist of the Year award for her contributions to equity,leadership,and breast cancer care. [28]
Jagsi remains an adjunct professor at the University of Michigan,where she leads its M-PACT cultural transformation center, [29] a $79M program that is supported by a U54 NIH FIRST grant on which she is PI together with Professor Robert Sellers.
In 2022,she began a new position leading the large Department of Radiation Oncology at Winship Cancer Institute of Emory University,which has multiple large sites of practice across the diverse metropolitan Atlanta area. She was recognized as a Fellow of the American Association for the Advancement of Science [30] and received ASTRO’s inaugural mentorship award. [31] She continues her bioethics work via her professional society service and as a Senior Faculty Fellow at Emory’s Center for Ethics.
Jagsi is married to John A. E. Pottow;they have two children. [10]
Olufunmilayo I. Olopade born in the year 1957,is a Nigerian hematology oncologist,Associate Dean for Global Health and Walter L. Palmer,Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
Ralph R. Weichselbaum is an American physician specializing in radiation oncology,a member of the Institute of Medicine of the National Academy of Sciences,Ludwig professor,He is Daniel K. Ludwig Distinguished Service Professor of Radiation Oncology and Chairman,Department of Radiation and Cellular Oncology,at the University of Chicago Pritzker School of Medicine,and Head of the University of Chicago Center for Radiation Therapy,and the director of the Chicago Tumor Institute. Weichselbaum is also Co- Director of the Ludwig Center for Metastasis Research at the University of Chicago.
Eric P. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital Yale New Haven Health System,effective February 1,2022. He also is Deputy Dean for Cancer Research at Yale School of Medicine. From 1997 to 2021,he was the Chief of the Breast Oncology Program at Dana–Farber Cancer Institute in Boston,Massachusetts. Beginning in 2013,he held a range of institutional roles at Dana-Farber,including Chief of Clinical Development,the Thompson Chair in Breast Cancer Research and Director of the Dana-Farber/Harvard SPORE in Breast Cancer. He also served as a Professor of Medicine at Harvard Medical School. He was president of the American Society of Clinical Oncology (ASCO) 2022-2023 and became Chair of the Board in mid-June 2023. His career has been focused on breast cancer treatment and research.
Winship Cancer Institute of Emory University is a nonprofit cancer research and patient care center based in Atlanta,Georgia. Winship Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center in Georgia.
Walter "Wally" J. Curran,Jr. is an American radiation oncologist specializing in the treatment of malignant brain tumors and locally advanced lung cancer.
Eleanor D. Montague was an American radiologist and educator who established breast-conserving therapy in the United States and improved radiation therapy techniques. She became a member of the Texas Women's Hall of Fame in 1993.
Nancy E. Davidson is the executive director and president of Seattle Cancer Care Alliance,senior vice president,director of clinical oncology at Fred Hutchinson Cancer Research Center and head of the Division of Medical Oncology at the University of Washington School of Medicine. She focuses her research on breast cancer treatments and the genes that are mutated in various forms of breast cancer. She was president of American Association for Cancer Research from 2015 to 2016 and president of American Society of Clinical Oncology from 2007 to 2008.
Sonja Eva Singletary was an American surgeon who specialized in the care of breast cancer. She was a faculty member at the University of Texas MD Anderson Cancer Center and a past president of the Society of Surgical Oncology.
Jay Steven Loeffler was an American physician at Massachusetts General Hospital,where he served as chair of the Department of Radiation Oncology since 2000. He was the Herman and Joan Suit Professor of Radiation Oncology and professor of neurosurgery at Harvard Medical School.
Kornelia Polyak is a professor of medicine at Harvard Medical School and an internationally recognized breast cancer expert.
Deborah Watkins Bruner is an American researcher,clinical trialist,and academic. She is the senior vice president for research at Emory University. Her research focus is on patient reported outcomes,symptom management across cancer sites,sexuality after cancer treatment,and effectiveness of radiotherapy modalities. Bruner's research has been continually funding since 1998,with total funding of her research exceeding $180 million. She is ranked among the top five percent of all National Institutes of Health-funded investigators worldwide since 2012,according to the Blue Ridge Institute for Medical Research.
Edith Peterson Mitchell (1947-2024) was a retired Brigadier general of the United States Air Force and an oncologist. She was clinical professor of medicine and medical oncology at Thomas Jefferson University. In 2015,she became the president of the National Medical Association.
Julie Kathleen Silver is an American medical researcher who is an Associate Professor in the Department of Physical Medicine and Rehabilitation at the Harvard Medical School. Her research considers musculoskeletal disorders and cancer rehabilitation. Silver is involved with several initiatives to improve gender equity in medicine. She is the 2022 recipient of the Elizabeth Blackwell Medal.
Tatiana Michelle Prowell is an American medical oncologist specializing in breast cancer. She is an Associate Professor of Oncology at Johns Hopkins School of Medicine and Breast Cancer Scientific Liaison at the U.S. Food &Drug Administration.
Bhuvaneswari Ramaswamy is an American breast medical oncologist and hematologist. She serves as section chief of Breast Medical Oncology and as director of the Medical Oncology Fellowship Program in Breast Cancer for The Ohio State College of Medicine.
Pamela Lyn Kunz is an American oncologist. She is the leader of the Gastrointestinal Cancers Program at Yale Cancer Center and Smilow Cancer Hospital and director of GI Medical Oncology within the Section of Medical Oncology. She was formerly the director of the Stanford Neuroendocrine Tumor Program before leaving,in part due to harassment. Kunz was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.
Allison Walsh Kurian is an American medical oncologist. She is a Professor of Medicine and Epidemiology &Population Health at Stanford University and an oncologist at the Stanford Cancer Institute.
Ann Hart Partridge is an American medical oncologist. She is the founder and director of the Young and Strong Program for Young Women with Breast Cancer at the Susan F. Smith Center for Women's Cancers at the Dana–Farber Cancer Institute.
Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer,with emphasis on intensity modulated radiotherapy in node positive breast cancer,the use of radiosensitizing agents,and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.
Mylin Ann Torres is an American breast cancer radiation oncologist. Torres is the Louisa and Rand Glenn Family Chair in Breast Cancer Research and director of the Glenn Family Breast Center.